KEYNOTE-811

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

KEYNOTE-811

Jan 11, 2025, 21:15 | Science

Senthil Kumar: Comprehensive Overview of First-Line Treatment for Metastatic Esophageal Cancer

Senthil Kumar, Medical Oncologist at Red Hills Chennai, shared a post on X: "Comprehensive Overview…

Oct 21, 2023, 19:04 | Insight

Sharlene Gill's summary of KEYNOTE-811 by Yelena Janjigian from ESMO23

Sharlene Gill shared on her Twitter: " KN811 Yelena Janjigian: ph3 HER2+ mG/GEJc chemo + trastuzumab +/-…

All: 2 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023